President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Other employees were told to work from home a day ahead of Israel's deadline for the agency to close up shop there and vacate the premises. Write to [email protected] Write to us at newsletters ...

A recent award ceremony which is actually significant revealed about the best companies right now existing in the country US ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

President Trump’s chief cost-cutter cheered an effort to persuade federal workers to quit — in a fashion that closely ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

The U.S. Department of Labor is looking to phase out sheltered work programs that are allowed to pay disabled workers less ...

Eli Lilly & Co. faced a skeptical Seventh Circuit Tuesday in arguing a lower court used a misplaced two-step process when it ...